Clinical Trial Update: A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating idecabtagene vicleucel with lenalidomide maintenance versus lenalidomide maintenance alone in adults with newly diagnosed multiple my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Abecma (idecabtagene vicleucel) (idecabtagene vicleucel)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING